Our Global Presence
Streamlining its global expansion strategy, ASPO Pharmaceuticals LLP has established a dedicated Export Regulatory Division
to comply with international audits and manage documentation including COPP, CTD dossiers, and regulatory filings.
ASPO operates in full compliance with WHO-GMP norms and ensures that every formulation meets the regulatory
expectations of international health authorities.
Our products have gained trust and approval in key emerging markets, including:
We are proud to serve these nations by providing safe, affordable, and quality-assured medications, contributing to
their healthcare infrastructure and public health needs.
ASPO is currently focused on expanding in Latin America, Central Asia, and the Middle East, backed by:
- Regulatory-compliant manufacturing
- Export dossier support (CTD/ACTD formats)
- Strategic partnerships with local distributors and government tenders
- Timely audit responsiveness and export readiness
With our unwavering focus on quality, service, and compliance, ASPO is well-positioned to be a trusted global partner in
healthcare.